Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study
- PMID: 38839092
- PMCID: PMC11151781
- DOI: 10.1136/bmj.q1237
Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study
Erratum for
-
Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study.BMJ. 2024 Apr 25;385:e078242. doi: 10.1136/bmj-2023-078242. BMJ. 2024. PMID: 38663919 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources